Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ubiquilin 2 Antikörper (AA 473-542) (Biotin)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch Ubiquilin 2 in ELISA. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7174229

Kurzübersicht für Ubiquilin 2 Antikörper (AA 473-542) (Biotin) (ABIN7174229)

Target

Alle Ubiquilin 2 (UBQLN2) Antikörper anzeigen
Ubiquilin 2 (UBQLN2)

Reaktivität

  • 51
  • 12
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 45
  • 6
Kaninchen

Klonalität

  • 46
  • 5
Polyklonal

Konjugat

  • 26
  • 5
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Ubiquilin 2 Antikörper ist konjugiert mit Biotin

Applikation

  • 32
  • 25
  • 18
  • 11
  • 7
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
ELISA
  • Bindungsspezifität

    • 6
    • 6
    • 6
    • 5
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 473-542

    Kreuzreaktivität

    Human

    Aufreinigung

    >95%, Protein G purified

    Immunogen

    Recombinant Human Ubiquilin-2 protein (473-542AA)

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    Ubiquilin 2 (UBQLN2)

    Andere Bezeichnung

    UBQLN2

    Hintergrund

    Background: Plays an important role in the regulation of different protein degradation mechanisms and pathways including ubiquitin-proteasome system (UPS), autophagy and the endoplasmic reticulum-associated protein degradation (ERAD) pathway. Mediates the proteasomal targeting of misfolded or accumulated proteins for degradation by binding (via UBA domain) to their polyubiquitin chains and by interacting (via ubiquitin-like domain) with the subunits of the proteasome (PubMed:10983987). Plays a role in the ERAD pathway via its interaction with ER-localized proteins FAF2/UBXD8 and HERPUD1 and may form a link between the polyubiquitinated ERAD substrates and the proteasome (PubMed:24215460, PubMed:18307982). Involved in the regulation of macroautophagy and autophagosome formation, required for maturation of autophagy-related protein LC3 from the cytosolic form LC3-I to the membrane-bound form LC3-II and may assist in the maturation of autophagosomes to autolysosomes by mediating autophagosome-lysosome fusion (PubMed:19148225, PubMed:20529957). Negatively regulates the endocytosis of GPCR receptors: AVPR2 and ADRB2, by specifically reducing the rate at which receptor-arrestin complexes concentrate in clathrin-coated pits (CCPs) (PubMed:18199683).

    Aliases: UBQLN2 antibody, N4BP4 antibody, PLIC2 antibody, HRIHFB2157Ubiquilin-2 antibody, Chap1 antibody, DSK2 homolog antibody, Protein linking IAP with cytoskeleton 2 antibody, PLIC-2 antibody, hPLIC-2 antibody, Ubiquitin-like product Chap1/Dsk2 antibody

    UniProt

    Q9UHD9
Sie sind hier:
Chat with us!